Ogremorphin

CAS No. 352563-21-4

Ogremorphin( —— )

Catalog No. M37230 CAS No. 352563-21-4

Ogremorphin (GPR68-IN-1) is a potent inhibitor of GPR68 with an EC50 of 170 nM, used in the study of autoimmune chronic inflammatory diseases .

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 606 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Ogremorphin
  • Note
    Research use only, not for human use.
  • Brief Description
    Ogremorphin (GPR68-IN-1) is a potent inhibitor of GPR68 with an EC50 of 170 nM, used in the study of autoimmune chronic inflammatory diseases .
  • Description
    Ogremorphin (GPR68-IN-1) is a potent GPR68 inhibitor with an EC50of 170 nM. Ogremorphin is extracted from patent WO2020214896 (OGM1), and can be used for autoimmune chronic inflammatory diseases research.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    GPR
  • Recptor
    GPR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    352563-21-4
  • Formula Weight
    359.44
  • Molecular Formula
    C21H17N3OS
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 50 mg/mL (139.11 mM; Ultrasonic )
  • SMILES
    O=C1NC2=CC=C(C=C2C31SC(=NN3)C=4C=CC=C5C=CC=CC54)CC
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Charles C. Hong, et al. Small molecule inhibitors of gpcr gpr68 and related receptors. Patent WO2020214896.
molnova catalog
related products
  • WAY-622024

    WAY-622024 is an agonist of the orphan human GPCR GPR109B.

  • Kisspeptin-10, human...

    Kisspeptin-10, human TFA is a potent vasoconstrictor and angiogenesis?inhibitor.?Kisspeptin-10, human TFA acts as a tumor metastasis suppressor via its receptor GPR54.?Kisspeptin-10-GPR54 system plays an important role in embryonic kidney development.

  • OX04528

    OX04528 is an orally active and potent GPR84 biased agonist.OX04528 inhibits cAMP signaling and may be useful in cancer research.